SLSN Company Profile and Key Details

SLSN has shown mixed momentum, losing -1.3% over the past week and -60.21% over the past quarter, though year-to-date performance is down -4.7%. Short-term trend indicators are bullishly aligned (SMA20 -1.61%, SMA50 -14.62%, SMA200 -56.19%). The stock’s 14-day RSI is 44.93 (neutral), while the ATR of 0.1 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -92.09% below its high and over 12.93% above its low. Average 10-day trading volume of 20.64 thousand shares is below the 3-month average of 94.59 thousand, indicating normal recent market interest.

Solesence, Inc. Common Stock has 70.63 million shares outstanding. The public float is 18.32 million shares, elevated short interest at 1.94% of float. This equals 397.31 thousand shares. The short ratio is 3.16 days. Institutional investors hold 20.26% of the float. Insiders own 73.09%.

Solesence, Inc. Common Stock last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around -$1.98. This means the shares are trading below this model’s fair value.

Solesence, Inc. Common Stock (NASDAQ:SLSN) closed at $0.81 USD, losing -$0.02 (-2.59%) from the previous close of $0.83. The stock is currently mid-range between its 52-week high and low $0.61 and $4.55. With a market capitalization of about $57.11 million, Solesence, Inc. Common Stock is classified as a micro-cap and shows market-like volatility (beta ~1.27). Key stats such as the average daily volume over the past year has been around 97.08 thousand shares, volume is running light vs its 52-week average. Headquartered in Romeoville, IL, Solesence, Inc. Common Stock operates in the Consumer Defensive sector and the Household & Personal Products industry. Led by CEO Kevin Cureton, the company employs approximately 115 people and listed since November 26, 1997. Solesence, Inc., formerly known as Nanophase Technologies Corporation, specializes in the development and production of clean-label, inclusive, and mineral-based skincare and cosmetic products.

Solesence, Inc. Common Stock trades at a P/E ratio of -32.17, slightly below the S&P 500 average, with a price-to-sales ratio of 1.06 and a price-to-book ratio of 4.46 trading at moderately above to book value. The P/FCF stands at -32.45, also below market averages.

Our AI price prediction model suggests that Solesence, Inc. Common Stock stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -6.01%, with price expected at $0.76 by September 25, 2026, within a range of $0.70 to $0.82 3-Month Outlook: Projected rise of 31.09%, reaching $1.06 by December 10, 2026, with a range of $0.94 to $1.17. 1-Year Outlook: Projected gain of 3.88%, with price at $0.84 by September 10, 2027, within a range of $0.65 to $0.92.

Solesence, Inc. Common Stock (NASDAQ:SLSN) shares are flat -4.7% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows Solesence, Inc. Common Stock trading at a premium to the broader market with a P/E of -32.17. Our AI forecast model points to short-term weakness (-6.01% over two weeks), a medium-term rise (31.09% over three months), and a longer-term gain (3.88% over one year), with expected trading ranges indicating moderate volatility.